Oxford Nanopore Technologies plc (ONTTF)
USD 1.8
(-7.69%)
USD 1.8
(-7.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -168.6 Million GBP | -71.21% |
| 2022 | -98.47 Million GBP | 40.15% |
| 2021 | -164.53 Million GBP | -125.2% |
| 2020 | -73.06 Million GBP | 9.68% |
| 2019 | -80.89 Million GBP | -30.1% |
| 2018 | -62.17 Million GBP | 5.63% |
| 2017 | -65.88 Million GBP | -1.43% |
| 2016 | -64.95 Million GBP | -46.91% |
| 2015 | -44.21 Million GBP | -5.25% |
| 2014 | -42.01 Million GBP | -45.17% |
| 2013 | -28.93 Million GBP | -23.35% |
| 2012 | -23.46 Million GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -77.02 Million GBP | 0.0% |
| 2023 Q2 | -74.78 Million GBP | -100.0% |
| 2023 Q3 | -46.91 Million GBP | 37.27% |
| 2023 Q4 | -93.82 Million GBP | -100.0% |
| 2023 FY | -168.6 Million GBP | -71.21% |
| 2023 Q1 | -37.39 Million GBP | 50.48% |
| 2022 Q4 | -75.51 Million GBP | -96.35% |
| 2022 Q1 | -10.77 Million GBP | 91.09% |
| 2022 Q2 | 14.93 Million GBP | 238.52% |
| 2022 Q3 | -38.46 Million GBP | -357.57% |
| 2022 FY | -98.47 Million GBP | 40.15% |
| 2021 Q1 | -21.62 Million GBP | 31.02% |
| 2021 FY | -164.53 Million GBP | -125.2% |
| 2021 Q4 | -120.96 Million GBP | -99.46% |
| 2021 Q2 | -43.57 Million GBP | -101.52% |
| 2021 Q3 | -60.64 Million GBP | -39.19% |
| 2020 Q4 | -31.34 Million GBP | -100.0% |
| 2020 Q1 | -20.85 Million GBP | 0.0% |
| 2020 Q2 | -41.71 Million GBP | -100.0% |
| 2020 Q3 | -15.67 Million GBP | 62.43% |
| 2020 FY | -73.06 Million GBP | 9.68% |
| 2019 FY | -80.89 Million GBP | -30.1% |
| 2018 FY | -62.17 Million GBP | 5.63% |
| 2017 FY | -65.88 Million GBP | -1.43% |
| 2016 FY | -64.95 Million GBP | -46.91% |
| 2015 FY | -44.21 Million GBP | -5.25% |
| 2014 FY | -42.01 Million GBP | -45.17% |
| 2013 FY | -28.93 Million GBP | -23.35% |
| 2012 FY | -23.46 Million GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | -134.877% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 3530.63% |
| SQZ Biotechnologies Company | -75.82 Million USD | -122.366% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -844.747% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 305.993% |
| Mesoblast Limited | -84.14 Million USD | -100.374% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -10876.798% |
| Genus plc | 6.4 Million USD | 2734.516% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 1830.662% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -18003.137% |
| Marizyme, Inc. | -34.08 Million USD | -394.65% |
| ContraFect Corporation | -56.88 Million USD | -196.382% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -1919.269% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -3601.847% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -11926.397% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -5815.053% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -6029.366% |
| MultiCell Technologies, Inc. | -722.81 USD | -23326777.049% |
| Accustem Sciences Inc. | -3.74 Million USD | -4400.538% |
| RVL Pharmaceuticals plc | -58.99 Million USD | -185.826% |
| EV Biologics, Inc. | -483.06 Thousand USD | -34804.215% |
| Q BioMed Inc. | -3.44 Million USD | -4793.436% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 4862.966% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -43180.797% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -6317.035% |
| Biomind Labs Inc. | -1 Million USD | -16600.525% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | -3355.425% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -2436.231% |
| Skye Bioscience, Inc. | -13.67 Million USD | -1133.261% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -8387.832% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -562830.689% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -3242.444% |
| IMV Inc. | -38.67 Million USD | -336.003% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -962.456% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -8624.419% |
| GB Sciences, Inc. | -1.42 Million USD | -11769.619% |
| Alpha Cognition Inc. | -9.7 Million USD | -1637.234% |
| HST Global, Inc. | -140.9 Thousand USD | -119559.776% |
| CSL Limited | 3.7 Billion USD | 104.555% |
| Halberd Corporation | -75.05 Thousand USD | -224562.225% |
| Enzolytics Inc. | -2.14 Million USD | -7746.659% |
| Resverlogix Corp. | -12.74 Million USD | -1222.527% |
| Affymax, Inc. | -15.04 Million USD | -1020.623% |
| SYBLEU INC | -149.18 Thousand USD | -112923.864% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -5221.794% |
| argenx SE | -425.04 Million USD | 60.332% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -203.756% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -16050.287% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -10575.814% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -4851.837% |
| AVAX Technologies, Inc. | 6.69 Million USD | 2619.229% |
| Zenith Capital Corp. | -8.94 Million USD | -1785.374% |
| Genscript Biotech Corporation | -415.79 Million USD | 59.449% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -967749.148% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -6767.097% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -98208.817% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -206.716% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -5711.598% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -17034.138% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -8943.752% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -13324.283% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -8310.446% |
| BioStem Technologies, Inc. | -7.77 Million USD | -2067.498% |
| ONE Bio Corp. | 13.68 Million USD | 1332.382% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -92805.199% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -12525.811% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -14888.719% |
| Agentix Corp. | -1.37 Million USD | -12191.472% |
| LadRx Corporation | -3.82 Million USD | -4309.662% |
| Cell Source, Inc. | -4.32 Million USD | -3798.162% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -40481.834% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -24444.581% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -24444.581% |
| NovAccess Global Inc. | -2.46 Million USD | -6735.241% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -5675.381% |
| Itoco Inc. | -919.14 Thousand USD | -18244.213% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -3878.115% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -14967.828% |
| Kadimastem Ltd | -3.04 Million USD | -5445.893% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -64321.953% |
| CytoDyn Inc. | -18.05 Million USD | -833.708% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -669780.81% |
| Mobile Lads Corp. | -554.55 Thousand USD | -30304.652% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -76513.292% |
| Qrons Inc. | -643.67 Thousand USD | -26094.66% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -29756.939% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -7461.352% |
| Rebus Holdings, Inc. | -664 Thousand USD | -25292.922% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -9183.001% |
| International Stem Cell Corporation | -663 Thousand USD | -25331.222% |
| Bioxytran, Inc. | -3.82 Million USD | -4313.678% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -320205.851% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -828852.802% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -364.923% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -10320.828% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -22813.968% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -5319.769% |
| Neutra Corp. | -229.48 Thousand USD | -73372.456% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -861.338% |
| PureTech Health plc | -146.19 Million USD | -15.328% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -684.552% |
| IXICO plc | -1.43 Million USD | -11633.403% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -1676.515% |
| Gelesis Holdings, Inc. | -121.8 Million USD | -38.424% |
| CSL Limited | 3.81 Billion USD | 104.423% |
| Cellectis S.A. | -108.85 Million USD | -54.89% |